4.7 Article

Design of Potent and Selective Hybrid Inhibitors of the Mitotic Kinase Nek2: Structure-Activity Relationship, Structural Biology, and Cellular Activity

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 7, Pages 3228-3241

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm201683b

Keywords

-

Funding

  1. NHS
  2. Cancer Research UK [C309/A8274, C24461/A10285]
  3. Wellcome Trust
  4. Association for International Cancer Research
  5. Royal Society
  6. ICR
  7. Cancer Research UK [11566] Funding Source: researchfish

Ask authors/readers for more resources

We report herein a series of Nek2 inhibitors based on an aminopyridine scaffold. These compounds have been designed by combining key elements of two previously discovered chemical series. Structure based design led to aminopyridine (R)-21, a potent and selective inhibitor able to modulate Nek2 activity in cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available